Genetic Evolution of a Helicobacter pylori Acid-Sensing Histidine Kinase and Gastric Disease by Krishna, Uma et al.
W&M ScholarWorks 
Arts & Sciences Articles Arts and Sciences 
2016 
Genetic Evolution of a Helicobacter pylori Acid-Sensing Histidine 
Kinase and Gastric Disease 
Uma Krishna 
Vanderbilt Univ, Sch Med, Dept Med, Div Gastroenterol Hepatol & Nutr, 2215 Garland Ave,1030C Med Res 
Bldg 4, Nashville, TN 37232 USA; 
Judith Romero-Gallo 
Vanderbilt Univ, Sch Med, Dept Med, Div Gastroenterol Hepatol & Nutr, 2215 Garland Ave,1030C Med Res 
Bldg 4, Nashville, TN 37232 USA; 
Giovanni Suarez 
Vanderbilt Univ, Sch Med, Dept Med, Div Gastroenterol Hepatol & Nutr, 2215 Garland Ave,1030C Med Res 
Bldg 4, Nashville, TN 37232 USA; 
Mark H. Forsyth 
Coll William & Mary, Dept Biol, Williamsburg, VA 23185 USA 
Follow this and additional works at: https://scholarworks.wm.edu/aspubs 
Recommended Citation 
Krishna, U., Romero-Gallo, J., Suarez, G., Azah, A., Krezel, A. M., Varga, M. G., ... & Peek Jr, R. M. (2016). 
Genetic evolution of a Helicobacter pylori acid-sensing histidine kinase and gastric disease. The Journal 
of infectious diseases, 214(4), 644-648. 
This Article is brought to you for free and open access by the Arts and Sciences at W&M ScholarWorks. It has been 
accepted for inclusion in Arts & Sciences Articles by an authorized administrator of W&M ScholarWorks. For more 
information, please contact scholarworks@wm.edu. 
The Journal of Infectious Diseases
B R I E F R E P O R T
Genetic Evolution of a Helicobacter
pylori Acid-Sensing Histidine Kinase
and Gastric Disease
Uma Krishna,1 Judith Romero-Gallo,1 Giovanni Suarez,1 Ayeetin Azah,3
Andrzej M. Krezel,4 Matthew G. Varga,2 Mark H. Forsyth,5 and Richard M. Peek Jr1,2
1Department of Medicine, Division of Gastroenterology, Hepatology and Nutrition, 2Department
of Cancer Biology, Vanderbilt University School of Medicine, and 3Meharry Medical College
School of Medicine, Nashville, Tennessee; 4Department of Biochemistry and Molecular
Biophysics, Washington University in St Louis, Missouri; and 5Department of Biology, The
College of William and Mary, Williamsburg, Virginia
Helicobacter pylori is the strongest risk factor for gastric adeno-
carcinoma, which develops within a hypochlorhydric environ-
ment. We sequentially isolated H. pylori (strain J99) from a
patient who developed corpus-predominant gastritis and hypo-
chlorhydia over a 6-year interval. Archival J99 survived signifi-
cantly better under acidic conditions than recent J99 strains.
H. pylori arsRS encodes a 2-component system critical for stress
responses; recent J99 isolates harbored 2 nonsynonymous arsS
mutations, and arsS inactivation abolished acid survival. In
vivo, acid-resistant archival, but not recent J99, successfully col-
onized high-acid-secreting rodents. Thus, genetic evolution of
arsS may influence progression to hypochlorhydia and gastric
cancer.
Keywords. H. pylori; hypochlorhydia; acid resistance.
Helicobacter pylori represents the strongest known risk factor
for the development of gastric cancer; yet only 2%–3% of colo-
nized persons ever develop this malignancy [1–3]. The most
common form of gastric cancer, intestinal-type gastric adenocar-
cinoma, progresses from normal mucosa to antral-predominant,
corpus-predominant, and atrophic gastritis, then to intestinal
metaplasia, and finally to dysplasia and adenocarcinoma. Dur-
ing this cascade, acid secretion becomes progressively impaired,
which is precipitated by the transition from antral-predominant
to corpus-predominant gastritis [4].
H. pylori has evolved to survive under highly acidic condi-
tions, and one mechanism that underpins the acid-resistant
phenotype is production of urease [5–7]. Another constituent
used by H. pylori within this context is the ArsRS 2-component
(ArsR and ArsS) signal transduction system, which regulates
genes involved in acid resistance, including urease [5, 6]. ArsS
is the sensory constituent of this 2-component system, and
the periplasmic domain of ArsS is required to detect external
changes in pH, whereas ArsR is the response component. As
acidity increases, ArsS undergoes autophosphorylation at histi-
dine 214 within the cytoplasmic kinase domain. Phosphorylat-
ed histidine 214 subsequently transfers the phosphate residue to
aspartic acid residue 52 on ArsR [5–7], liberating ArsR to func-
tion as a transcription factor regulating expression of urease
complex components, amidases, and carbonic anhydrase [5–
7]. These data suggest that modifications in the ability to re-
spond to gastric acid may differ in H. pylori strains predisposed
to the development of intestinal-type gastric adenocarcinoma.
To address this hypothesis, we used a unique set of paired
H. pylori isolates [8]. Archival H. pylori strain J99 is a fully se-
quenced human clinical strain; 6 years after isolating this strain,
the source patient underwent repeat endoscopy, and new (re-
cent) J99 isolates were harvested. We now use these unique sam-
ples to define differences in acid survival, genetic evolution,
topography of inflammation, and the ability of strains to colo-
nize in vivo acidic niches, as a means to understand how a sub-
set of H. pylori–infected individuals may be predisposed toward
carcinogenesis.
MATERIALS AND METHODS
Bacterial Strains
Archival H. pylori strain J99 was isolated from a gastric biopsy
specimen from a patient with a duodenal ulcer [8]. The source
patient refused antimicrobial treatment and underwent repeat
endoscopy 6 years after the original J99 strain was isolated,
and new (recent) J99 isolates were obtained. Pooled H. pylori
isolates were used for these studies. Histopathologic parameters
of inflammation were determined as reported elsewhere [9]. All
procedures were approved by the Vanderbilt University (IRB
000109) and Nashville Department of Veterans Affairs (IRB
5910) institutional review boards.
H. pylori strains were grown for 16–18 hours in Brucella
broth with 10% fetal bovine serum [10] and then inoculated
into broth adjusted to a pH of 5.0 or 7.0, incubated for 60 min-
utes, and plated by serial dilution. After 4 days, colonies were
counted.
Construction of arsS Deletion and Reconstituted Mutants
The isogenicH. pylori J99 arsSmutant strain was constructed as
follows: 3′ and 5′ recombination flanking sequences of arsS
were amplified from J99 chromosomal DNA. The 3′ region
was amplified using primers containing restriction enzyme
sites, CTGAGCGGCCGCTTGTCGCTTTGTTTATGATAACGC
(NotI) and CTGATCTAGATTTCTATTGTGGTTTCTCTAAA
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GCC (XbaI), and then cloned into pBSC301 vector containing a
kanamycin cassette. The 5′ flanking arsS sequence was amplified
using the primers CTGAGAATTCGGTGTCCAATAAAAGCA
AACCTT (EcoRI) and CTGAGGTACCCCCTTCATTCCCTT
CACCTC (KpnI) and cloned into the pBSC103 construct contain-
ing the 3′ flanking sequence. The resultant plasmid was used for
H. pylori natural transformation with selection using 25 µg/mL
kanamycin.
To generate an archival J99 mutant that harbors the recent J99
arsS, a 4286–base pair region containing the 3′ end of arsR
( jhp0152), arsS, hemB, jhp0149, and the 3′ end of jhp0148 was
amplified from recent J99 DNA using forward primer 5′
GATTGAGAGCGAGAGCATCAACCC3″ and reverse primer
5′CATTTGGTGGCTACAACCGGTGAG3″. Amplicons were
then cloned into the pGEM-T Easy vector system. A chloram-
phenicol resistance cassette, CAT, was excised as an EcoRV/SmaI
fragment from pBSC103 and ligated into a blunt-ended BamHI
site in the intergenic region between jhp0149 and jhp0148 to
avoid disrupting arsS transcription. The resulting plasmid was
naturally transformed into the archival J99 strain and selected
using 10 µg/mL chloramphenicol. Sequencing confirmed that
the 2 recent J99 arsSmutations were incorporated into the archi-
val J99 genome.
Animal Models
All procedures were approved by the Institutional Animal Care
and Use Committee of Vanderbilt University. Male C57BL/6
mice were purchased from Harlan Laboratories, and male Mon-
golian gerbils were purchased from Charles River Laboratories.
Gerbils and mice were challenged [10] with either Brucella
broth or H. pylori (109 colony-forming units per animal) and
euthanized 2 weeks after the challenge.
Statistical Analysis
Analysis of variance Tukeymultiple comparisons test (Figure 1A),
2-tailed χ test (Figure 1B), and 2-tailed Mann–Whitney U test
(Figures 1C, 1D, and 2D) were used in GraphPad Prism software
(version v5.0a). Differences were considered statistically significant
at P < .05. Data are expressed as means with standard deviations.
RESULTS AND DISCUSSION
A shift in the pattern of H. pylori–induced inflammation from
antral-predominant to corpus-predominant gastritis is a crucial
step in the cascade to gastric carcinogenesis. Therefore, we first
sought to determine whether histologic progression toward a
carcinogenic phenotype occurred over time in the J99 source
patient. Total inflammation scores in the gastric antrum were
3-fold higher than scores in the corpus at the initial endoscopy
(P < .05); however, this pattern was reversed 6 years later, when
the severity of corpus inflammation was approximately 3-fold
that of antral inflammation (P < .05; Figure 1A). Importantly,
the patient had not been treated with proton pump inhibitors
(PPIs) during the 6-year interval, indicating that proximal mi-
gration of inflammation in the stomach was not mediated by
PPI therapy. When endoscopy was repeated, the gastric pH
was 5.0, further indicating that acid secretion was impaired.
The transition from antral- to corpus-predominant gastritis
suggested that this patient was progressing toward a hypochlo-
rhydric phenotype and may be at higher risk for intestinal-type
gastric adenocarcinoma.
We then extended these findings into 2 rodent models, Mon-
golian gerbils and C57BL/6 mice, which develop different
inflammation and acid-related phenotypes in response to
H. pylori. Mongolian gerbils are outbred and develop antral-
predominant gastritis after acute H. pylori infection [11] in con-
trast to inbred mice, which develop corpus-predominant gastritis
[12]. After challenge with the archival or recent J99 isolates for
2 weeks, only the H. pylori archival strain successfully infected
gerbils (P = .04 vs recent J99; Figure 1B). However, the pattern
of colonization density and efficiency differed in mice. Although
all mice challenged with archival or recent H. pylori J99 isolates
were successfully colonized (data not shown), colonization den-
sity was significantly increased (P = .008) in mice infected with
recent J99 isolates compared with those infected with archival
J99 (Figure 1C).
Given the inherent differences in inflammatory responses
and the outbred versus inbred nature of these models, we recog-
nize that other mediators could contribute to these results. For
example, BabA is an outer membrane protein encoded by the
babA2 gene, which binds to fucosylated Lewisb antigen on the
surface of gastric epithelial cells [2, 3]. babA2 is associated with
gastric cancer, but BabA expression can be lost in H. pylori iso-
lates retrieved from human samples, as well as in mice and ger-
bils infected with H. pylori [2, 3]. Loss of BabA may provide a
mechanism through which H. pylori can modify its outer mem-
brane to adapt to changing conditions within an inflamed
milieu. SabA is another H. pylori adhesin that binds to the sial-
yl-Lewisx antigen expressed on gastric epithelium and is associated
with increased gastric cancer risk [2, 3]. Sialyl-Lewisx expression is
induced during chronic gastric inflammation, suggesting that
H. pylori modulates host cell glycosylation patterns to enhance
attachment and colonization [2, 3]. Importantly, our animal re-
sults phenocopy findings from the human studies, because ar-
chival J99 isolates harvested from an acidic gastritis phenotype
(antral-predominant gastritis) more robustly colonize high-
acid-producing rodents (gerbils), whereas the converse is true
for recent J99 isolates.
We then examined the capacity of the archival and recent J99
isolates to survive under different pH conditions in vitro as a
means to understand differences observed in vivo. Archival
H. pylori strain J99 survived significantly better (P = .008)
than recent J99 isolates under pH 5.0 but not pH 7.0 conditions,
indicating that the archival strain is more resistant to an acidic
environment (Figure 1D).
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Based on their known roles in acid response, the genes en-
coding ArsR and ArsS were completely sequenced in both iso-
lates to identify potential mutations. There were no differences
in arsR nucleotide identity between the strains (data not
shown). However, when the arsS sequence of archival J99 was
compared with that of the recent J99 isolate, 2 nonsynonymous
point mutations were identified in the latter. At amino acid po-
sition 42, cysteine was substituted for arginine, and at amino
acid position 97, glycine was substituted for tryptophan (Fig-
ure 2A). Ten additional single colony isolates from each pooled
J99 strain were then sequenced, and all of the single colony iso-
lates harbored arsS sequences that were identical to the respec-
tive pooled parental strains (data not shown).
To determine the potential impact of this 2-residue difference
between the strains, we constructed homology models of the
archival and recent forms of the ArsS sensor domains. The
structure of the Helicobacter acinonychis ArsS sensor domain,
which is 86% identical to its orthologue in H. pylori J99, was
used as a template in Modeller (version 9.16) software calcula-
tions [13]. Side chains containing the amino acid changes with-
in the archival and recent sensor domains of ArsS are both
surface exposed (Figure 2B). The Trp97 to Gly mutation is lo-
cated in a predicted reverse turn between 2 strands of the cen-
tral β-sheet (Figure 2B), which may affect conformational
responses of this domain to changes in pH, and the second mu-
tation at position 42 replaces a charged Arg to a noncharged
Cys side chain and is located at the beginning of the predicted
first α-helix (Figure 2B). The location of the amino acid substi-
tutions within the periplasmic domain of ArsS suggest that
ArsS in the recent J99 isolates may be limited in its ability to
respond to changes in acidity.
We also investigated potential isolate-specific differences in
H. pylori arsS expression and found that archival J99 expressed
arsS to levels that were significantly higher than the recent J99 iso-
late at pH 5.0 (Figure 2C). Thus, the ability of arsS to mediate acid
survival in archival J99 may be regulated both by transcriptional
Figure 1. Patterns of inflammation, colonization, and acid survival induced by archival versus recent Helicobacter pylori J99 isolates. A, Two antral biopsy specimens were
obtained at each endoscopy from a single site 2–6 cm from the pylorus on the greater curvature of the stomach and were used for histopathologic examination. Similarly, 2
corpus biopsy specimens were obtained at each endoscopy from a single site 6–10 cm proximal to the termination of the gastric rugae on the greater curvature of the stomach.
For each specimen, 10 high-powered fields were examined. Acute and chronic inflammation were each graded 0–3 in the gastric antrum and corpus, for a cumulative score
ranging from 0 to 6, and data represent mean histologic scores from the 2 biopsy specimens at each site at each point in time. *P < .05; †P < .01. B, Mongolian gerbils were
challenged with the H. pylori archival or recent J99 strains. Two weeks after infection, they were euthanized, and their stomachs harvested. One-fourth of the stomach was
homogenized in sterile phosphate-buffered saline, as reported elsewhere [10]. After serial dilution, samples were plated on selective trypticase soy agar plates with 5% sheep
blood containing vancomycin, nalidixic acid, bacitracin, and amphotericin B and were incubated at 37°C with 5% carbon dioxide for 5–7 days. Colonization efficiency was
expressed as the percentage of gerbils colonized versus the percentage gerbils challenged (n = 5 per group). ‡P = .04. C, Colonization density in wild-type C57Bl/6 mice (n = 5 per
group) was determined by means of quantitative culture. §P = .008. CFUs, colony-forming units (CFUs). D, Archival and recent J99 strains were cultured in Brucella broth
adjusted to a pH of 5.0 or 7.0 and incubated for 60 minutes. Bacteria were then plated by serial dilution, and colonies were counted. §P = .008. Abbreviation: NS, not significant.
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up-regulation of arsS and by an enhanced capacity to sense
changes in pH.
To more definitively determine the role of ArsS in the ob-
served phenotypic changes, arsS was inactivated in the archival
and recent J99 strains. Disruption of arsS in the archival strain
significantly attenuated (P = .02) its ability to survive under
acidic conditions; however, disruption of arsS in the recent
J99 isolate had no effect on acid survival (Figure 2D). We also
generated a mutant of archival J99 that contained the arsS se-
quence from the recent J99 strain and infected gerbils to further
define the role of arsS in colonization and acid tolerance in vivo.
Four of 5 gerbils challenged with the original archival J99 strain
were successfully colonized, compared with none of the 5 gerbils
challenged with the mutant strain (P = .01). These results
Figure 2. The role of arsS in mediating acid survival in archival and recent Helicobacter pylori isolates. A, The arsS sequence from the archival J99 isolate was compared that
from the recent J99 isolate, and 2 nonsynonymous point mutations were identified in the recent isolate. At amino acid position 42, cysteine was substituted for arginine, and at
position 97, glycine was substituted for tryptophan (red). B, Ribbon diagram of a model of the ArsS sensor domain (residues 41–125). Arrows indicate connections to the
putative transmembrane helices of ArsS. Side chains containing residues 42 and 97 are enlarged. C, Changes in H. pylori arsS expression in response to pH 5.0. RNA was
isolated from H. pylori grown in broth adjusted to pH 5.0 or 7.0 using the RNeasy RNA purification kit (Qiagen). Reverse-transcriptase polymerase chain reaction (PCR) was
performed using a High Capacity cDNA Reverse Transcription kit (Applied Biosystems), followed by reverse-transcriptase PCR using the SYBR Green Gene Expression Assay and
a 7300 real-time PCR system (Applied Biosystems), with the following primers: arsS, 5′ AAGTGAAACGCTTCGCTCAAG 3′ and 5′ ATTCGTTAGCCAAATCCCCTATT 3′; 16S, 5′
TGCGAAGTGGAGCCAATCTT 3′ and 5′ GGAACGTATTCACCGCAACA 3′. Relative gene expression levels were calculated using the 2−ΔΔCT method. Levels of arsS expression at
pH 5.0 and pH 7.0 were then normalized to levels of 16S messenger RNA expression, and data are represented as the ratio of pH 5.0 to pH 7.0; 3 independent experiments were
conducted. †P = .003 (archival vs recent J99). D, Archival and recent wild-type (wt) J99 strains and their arsS isogenic mutants were cultured in Brucella broth that had been
adjusted to a pH of 5.0 or 7.0 and then incubated for 60 minutes. Bacteria were then plated by serial dilution, and colonies were counted. *P = .02. Abbreviations: CFUs, colony-
forming units; NS, not significant. This figure is available in black and white in print and in color online.
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reinforce our previous findings indicating that the recent J99
strain cannot successfully colonize a high-acid-producing ro-
dent model of infection and further indicate that mutations at
amino acid positions 42 and 97 are probably required for this
phenotype.
In summary, these results suggest that arsS may influence
the progression of gastric carcinogenesis. However, it will be
critically important to validate these findings in other human
populations with and without gastric cancer as well as within
unique patient cohorts. These include H. pylori–infected
human patients followed up longitudinally for years [14]
(similarly to the J99 source patient) or patients who have
been exposed to therapeutic agents such as PPIs, which alter
acidity and accelerate the progression from antral-predominant
to corpus-predominant gastritis, which is accompanied by gas-
tric atrophy [15]. Collectively, our current results provide an
important framework to define the roles of regulatory genes
within the context of H. pylori infection and disease within
the stomach.
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